First experience with extended release tacrolimus in the treatment of adult patients with severe, difficult to treat atopic dermatitis: Clinical efficacy, safety and dose finding

J Dermatol Sci. 2016 Jan;81(1):66-8. doi: 10.1016/j.jdermsci.2015.10.013. Epub 2015 Oct 28.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Calcineurin Inhibitors / administration & dosage*
  • Calcineurin Inhibitors / adverse effects
  • Calcineurin Inhibitors / blood
  • Cyclosporine / adverse effects
  • Cyclosporine / therapeutic use
  • Delayed-Action Preparations
  • Dermatitis, Atopic / blood
  • Dermatitis, Atopic / drug therapy*
  • Drug Evaluation
  • Female
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / blood
  • Male
  • Middle Aged
  • Tacrolimus / administration & dosage*
  • Tacrolimus / adverse effects
  • Tacrolimus / blood
  • Treatment Outcome
  • Young Adult

Substances

  • Calcineurin Inhibitors
  • Delayed-Action Preparations
  • Immunosuppressive Agents
  • Cyclosporine
  • Tacrolimus